Dolby
DLB
$58.81
+13.58%
Dolby Laboratories, Inc. is a technology company that develops audio and imaging technologies, licensing its intellectual property and selling cinema hardware and services to enhance media experiences across movies, TV, music, and sports. As a market leader in high-fidelity audio and imaging standards, Dolby's brand is synonymous with premium entertainment quality, and its licensing model generates recurring revenue from a broad ecosystem of device manufacturers and content creators. The current investor narrative centers on the company's recent earnings report, which delivered mixed results and triggered a sharp stock price surge, while analysts debate whether the high valuation justifies the growth prospects, with some suggesting investors consider taking profits.…
DLB
Dolby
$58.81
Related headlines
Investment Opinion: Should I buy DLB Today?
Based on the analysis, DLB is rated a Hold. The average analyst target price of $78.33 implies a 33.2% upside, but the negative PEG ratio and underperformance suggest caution. The company's high gross margin of 88.13% and low debt provide a solid foundation, but the mixed earnings and high trailing PE of 27.21 warrant a wait-and-see approach. The stock is currently trading at $58.81, near the lower end of its 52-week range, offering potential value if growth materializes. However, the negative PEG ratio and lack of analyst consensus (recommendation 'none') increase uncertainty. This Hold rating would upgrade to Buy if the company demonstrates consistent earnings growth and the PEG ratio turns positive, or downgrade to Sell if revenue growth decelerates further. Overall, DLB is fairly valued relative to its history, but the market is pricing in growth that may not materialize.
Sign up to view all
DLB 12-Month Price Forecast
The AI assessment is neutral with medium confidence. Dolby's high gross margins and low debt are positive, but the negative PEG ratio and significant underperformance temper enthusiasm. The stock appears fairly valued with potential upside if growth accelerates, but downside risks remain if earnings decline. Key factors to watch include revenue growth trends and adoption of new technologies. Upgrading to bullish would require evidence of accelerating growth and a positive PEG ratio, while downgrading to bearish would occur if revenue declines or competitive pressures intensify.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Dolby's 12-month outlook, with a consensus price target around $78.33 and implied upside of +33.2% versus the current price.
Average Target
$78.33
0 analysts
Implied Upside
+33.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$60 - $90
Analyst target range
Analyst coverage is limited with only 3 analysts, and the consensus recommendation is 'none', indicating a lack of strong bullish or bearish sentiment. The average target price is $78.33, implying a 33.2% upside from the current price of $58.81, which is bullish. The target range is wide, from $60.00 low to $90.00 high, reflecting high uncertainty. The low target suggests a modest 2% upside, while the high target implies a 53% upside, indicating divergent views on the company's future. The wide spread and limited coverage suggest that DLB is a mid-cap stock with moderate institutional interest, leading to higher volatility and less efficient price discovery.
Bulls vs Bears: DLB Investment Factors
Dolby Laboratories presents a mixed investment case. On the bullish side, its high gross margins, strong balance sheet, and analyst target upside of 33.2% are compelling. However, the negative PEG ratio, significant underperformance, and high trailing PE raise concerns about growth sustainability. The most important tension is whether the company can deliver the earnings growth implied by its forward PE of 12.79, or if the negative PEG ratio signals a decline. Currently, the bearish evidence is slightly stronger due to the negative PEG and underperformance, but the low debt and high margins provide a safety net. Investors should monitor upcoming earnings for signs of growth acceleration or deceleration.
Bullish
- High Gross Margin: Dolby's gross margin is exceptionally high at 88.13%, reflecting its asset-light licensing model. This allows for strong profitability and cash generation, with operating margin at 19.64% and net margin at 18.90%.
- Low Debt and Strong Liquidity: The balance sheet is conservative with a debt-to-equity ratio of 0.0148 and a current ratio of 3.17, indicating ample liquidity and low financial risk. This provides a solid foundation for weathering economic downturns.
- Analyst Target Upside: The average analyst target price is $78.33, implying a 33.2% upside from the current price of $58.81. Even the low target of $60.00 suggests a modest 2% upside, indicating that analysts see limited downside.
- Positive Cash Flow and Dividend: The company generates positive cash flow with a price-to-cash-flow ratio of 14.70, supporting a dividend yield of 1.82%. The payout ratio of 49.6% indicates sustainable dividend payments.
Bearish
- Negative PEG Ratio: The PEG ratio is -9.32, indicating that earnings are expected to decline. This is a red flag for growth investors, as it suggests that the forward PE of 12.79 may not be justified by future earnings growth.
- Significant Underperformance: DLB has underperformed the S&P 500 by 40.13% over the past year, with a 1-year price change of -21.94%. This persistent underperformance reflects investor concerns about the company's growth prospects.
- High Valuation on Trailing Earnings: The trailing PE is 27.21, which is likely at a premium to the industry average. This suggests that the market is pricing in significant growth, but the negative PEG ratio warns of potential earnings headwinds.
- Mixed Recent Earnings: The recent earnings report delivered mixed results, leading to a sharp stock price surge but also prompting analysts to suggest taking profits. This indicates uncertainty about the company's near-term performance.
DLB Technical Analysis
Over the past year, DLB has been in a clear downtrend, with the stock price declining 21.94% from 52-week highs, currently trading at $58.81, which is 77.7% of its 52-week range (low $48.26, high $75.66). The stock is near the lower end of its range, indicating bearish sentiment and potential value opportunity, but also risk of further downside if support fails. The 6-month price change of -8.38% confirms the intermediate-term downtrend, while the 1-year relative strength versus SPY is -40.13%, showing significant underperformance.
Beta
0.81
0.81x market volatility
Max Drawdown
-36.8%
Largest decline past year
52-Week Range
$48-$76
Price range past year
Annual Return
-21.9%
Cumulative gain past year
| Period | DLB Return | S&P 500 |
|---|---|---|
| 1m | +11.8% | +0.3% |
| 3m | +2.3% | +4.0% |
| 6m | -8.4% | +8.3% |
| 1y | -21.9% | +20.2% |
| ytd | -7.4% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
DLB Fundamental Analysis
Dolby's revenue trajectory shows mixed signals: the most recent quarterly revenue is estimated at $1.54 billion (forward estimate), but the company's growth has been decelerating, with a 1-year price change of -21.94% reflecting investor concerns. The gross margin is exceptionally high at 88.13%, indicating a strong licensing business model, but net margin is 18.90%, and operating margin is 19.64%, showing healthy profitability. The company is profitable with EPS of $0.037 (trailing), but the forward PE of 12.79 suggests the market expects earnings growth, while the PEG ratio of -9.32 is negative, indicating potential earnings decline. The balance sheet is conservative with a debt-to-equity ratio of 0.0148 and a current ratio of 3.17, providing ample liquidity, and the company generates positive cash flow with a price-to-cash-flow ratio of 14.70, supporting its dividend yield of 1.82%.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is DLB Overvalued?
Given positive net income, the primary valuation metric is the PE ratio. The trailing PE is 27.21, while the forward PE is 12.79, implying the market expects significant earnings growth, which is optimistic given the negative PEG ratio. Compared to the industry average (not provided), DLB's PE of 27.21 is likely at a premium, but the forward PE suggests a discount if growth materializes. Historically, the stock's valuation is near the lower end of its range, as the price has fallen 21.94% over the past year, making the current PE more attractive than in the past, but the negative PEG ratio warns of potential earnings headwinds.
PE
27.2x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks: Dolby's financial health is generally strong, but the negative PEG ratio of -9.32 indicates that earnings are expected to decline, which could pressure the stock. The company's net margin of 18.90% and operating margin of 19.64% are healthy, but any margin compression could impact profitability. The forward PE of 12.79 suggests the market expects growth, but if earnings decline, the stock could face de-rating. The company's revenue concentration in licensing and cinema hardware could be vulnerable to shifts in consumer behavior or technology disruption. The debt-to-equity ratio of 0.0148 is minimal, but the current ratio of 3.17 provides ample liquidity, reducing financial distress risk.
FAQ
The key risks of holding DLB include: 1) Earnings decline risk, as indicated by the negative PEG ratio of -9.32, which could lead to a de-rating. 2) Competitive risk from new audio and imaging technologies that could disrupt Dolby's licensing model. 3) Macroeconomic risk, as a downturn could reduce consumer electronics demand, impacting licensing revenue. 4) Valuation risk, as the trailing PE of 27.21 is high, and any earnings miss could trigger a sell-off. The most severe risk is a prolonged earnings decline, which could push the stock down to the 52-week low of $48.26, a 18% drop from current levels.
The DLB stock forecast over the next 12 months is cautiously optimistic. The base case scenario, with a 50% probability, sees the stock trading around the average analyst target of $78.33, implying a 33.2% upside. The bull case, with a 30% probability, targets $90, while the bear case, with a 20% probability, could see the stock fall to $48.26. The most likely scenario is moderate growth, assuming the company maintains its licensing revenue and expands into new markets. However, the negative PEG ratio suggests that earnings could decline, which would make the bear case more likely. Investors should monitor quarterly earnings for signs of growth or decline.
DLB's valuation is mixed. The trailing PE of 27.21 is likely at a premium to the industry average, suggesting the stock is not cheap. However, the forward PE of 12.79 implies that the market expects significant earnings growth, which could make it undervalued if that growth materializes. The negative PEG ratio of -9.32, though, warns that earnings are expected to decline, which would make the stock overvalued. Compared to its own history, the stock is trading near the lower end of its 52-week range, indicating potential value. Overall, the market is pricing in growth that may not be realized, so the stock is fairly valued to slightly overvalued.
DLB is a moderate buy at current levels. The average analyst target price of $78.33 implies a 33.2% upside, and the company's high gross margin of 88.13% and low debt provide a solid foundation. However, the negative PEG ratio of -9.32 and underperformance relative to the S&P 500 over the past year indicate potential earnings headwinds. For long-term investors with a tolerance for volatility, DLB could be a good addition, but it is not a high-growth stock. It is more suitable for those seeking a stable, dividend-paying company with a strong competitive position.
DLB is more suitable for long-term investment due to its stable business model, high gross margins, and dividend yield of 1.82%. The stock has a beta that is not provided, but its 1-year underperformance of -21.94% indicates volatility, making it less suitable for short-term trading. The company's earnings visibility is moderate, with a forward PE of 12.79, but the negative PEG ratio adds uncertainty. For long-term investors, a minimum holding period of 3-5 years is recommended to allow the company to capitalize on its technology leadership and potential growth in new markets. Short-term traders may find opportunities in the stock's volatility, but the lack of clear catalysts makes it less attractive for short-term plays.